ArticleBMC cancer2018

Variant isoforms of CD44 involves acquisition of chemoresistance to cisplatin and has potential as a novel indicator for identifying a cisplatin-resistant population in urothelial cancer.

Masayuki Hagiwara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.